Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Non-Staff Directors Get 50-Percent Raise; Increase Brings Remuneration to $30K Per Director

NEW YORK, Jan. 7 (GenomeWeb News) - Non-employee Affymetrix directors will get a 50-percent increase in the annual fee the company pays them for their services, Affymetrix said in a filing with the US Securities and Exchange Commission yesterday.

 

The six non-employee members will receive $30,000 a year, up from $20,000, the company said.

 

The company's non-employee directors are: Susan Desmond-Hellmann, president of product development at Genentech; John Diekman, managing partner of 5AM Ventures; Vernon Loucks, chairman of The Athena Group; David Singer, chairman of Oscient Pharmaceuticals; and John Young, retired president and CEO of Hewlett-Packard.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.